Login
$SPRO
$0.93 -$0.02 (1.73%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Timothy Keutzer
Chief Operating Officer
58 Since 2023
3 years
2015 $1,440,820
Debra Zack
Chief Medical Officer
Title from the Form 4 dated Aug 3, 2026
Not stated Not stated Not stated Not reported
Esther Rajavelu Also a director
See Remarks
Title from the Form 4 dated Nov 6, 2026
47 Not stated Not stated $2,061,496

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 27, 2026 · updated by the 8-K of Nov 10, 2026

Directors
8
serving now
Independent
5 of 7
stated in the proxy; 1 not stated
Average tenure
6.9 years
from year joined
CEO also chairs the board
No
Frank E. Thomas
Director Age On board Independent Committees Other public boards 2025 pay Source
Frank E. Thomas
56 2017
9 years
Independent None stated Larimar Therapeutics Inc. $187,800
Esther Rajavelu
47 2025
1 year
Not independent None stated None stated Paid as CEO
Milind Deshpande
69 2014
12 years
Independent None stated None stated Not stated
Scott Jackson
61 2020
6 years
Independent None stated MacroGenics, Inc. $115,300
John C. Pottage, Jr.
73 2018
8 years
Not independent None stated None stated $332,800
Cynthia Smith
57 2019
7 years
Independent None stated Agios Pharmaceuticals, Inc., Akebia Therapeutics, Inc., Protara Therapeutics, Inc., Tvardi Therapeutics, Inc. $117,800
Kathleen Tregoning
55 2021
5 years
Independent None stated None stated $107,800
William Ho Joined Nov 10, 2026
- - -
Development Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 27, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support